SEC Form 4 · accession 0001140361-17-032651
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Sofia
Officer — Chief Scientific Officer
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 7:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 15, 2017 | S | 10,000 | $3.75 | D | 191,412 | I | Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). |
| Common Shares | Aug 15, 2017 | S | 20,000 | $3.675 | D | 171,412 | I | Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). |
| Common Shares | holding | — | — | — | 1,563,403 | D |
Table II — derivative securities
No Table II lines on this filing.